¾È³çÇϼ¼¿ä ö±ÕÀÔ´Ï´Ù.
À̹ø¿¡ Á¦°¡ ¹ßÇ¥µå¸± ³í¹®ÀÇ Á¦¸ñÀº
"Antigen transfer from non-APCs to APCs impacts the efficacy and safety of protein- and mRNA- based vaccines"
À¸·Î Áö³ÇØ 10¿ù¿¡ Nano today (IF: 19.49)¿¡ ¹ßÇ¥µÈ ³í¹®ÀÔ´Ï´Ù.
mRNA ¹× protein ÇüÅÂÀÇ vaccineµéÀÌ ±×µ¿¾È È¿°úÀûÀÎ ¹æ¾î¸é¿ªÀ» À¯µµÇϱâ À§Çؼ´Â APC¸¦ ¸Å°³ÇØ¾ß ÇϹǷΠAPC¸¦ Ÿ°ÙÇÏ·Á´Â ¿©·¯ ½ÃµµµéÀÌ ±×µ¿¾È ¸¹ÀÌ º¸°í°¡ µÇ¾ú°í, À̸¦ À§ÇÑ ´Ù¾çÇÑ ³ª³ë¹°ÁúµéÀÌ °í¾ÈµÇ¾ú½À´Ï´Ù.
À̹ø ³í¹®¿¡¼´Â APC¿¡ Á÷Á¢ Àü´ÞµÇ´Â °Í »Ó¸¸ ¾Æ´Ï¶ó, APC°¡ ¾Æ´Ñ ´Ù¾çÇÑ ÀÏ¹Ý ¼¼Æ÷(non-APC)·Î ºÎÅÍ APC¿¡ Àü´Þ µÇ´Â °ÍÀÌ ¹é½ÅÀÇ È¿°ú ¹× ¾ÈÀü¼º¿¡ ±â¿©ÇÑ´Ù´Â ºÎºÐÀ» ¹àÇû½À´Ï´Ù.
ÀúÈñ´Â ´ëºÎºÐ ¸é¿ª¼¼Æ÷¿¡ ÃÊÁ¡À» µÎ°í ½ÇÇèÀ» ÇÏÁö¸¸, ÇØ´ç ³í¹®¿¡¼ ¹àÈ÷°í ÀÖ´Â ´Ù¸¥ ¿©·¯ ¼¼Æ÷µéÀÇ °ü¿©°¡ Æò¼Ò ¿¬±¸½Ç ³»¿¡¼µµ Á¾Á¾ ³íÀÇ°¡ µÇ´ø ºÎºÐÀ̾úÀ¸¸ç, Èï¹Ì·Î¿î ÁÖÁ¦¶ó°í »ý°¢ µË´Ï´Ù.
Åä¿äÀÏ¿¡ ºË°Ú½À´Ï´Ù.
ö±Õ ¿Ã¸².
³í¹®¸µÅ© : https://doi.org/10.1016/j.nantod.2021.101326